MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4874 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-09 (pharmiweb.com)
Bone Graft Substitutes Market (2024-2035) – Trends, Growth Drivers, and Future Outlook -
Market OverviewThe global Bone Graft Substitutes Market is valued at USD 4.04 Billion in 2024 and is projected to reach a value of USD 8.26 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.75% between 2025 and 2035. With a growing demand for advanced, minimally invasive procedures and a global rise in bo...
Read more
2025-04-09 (fool.com)
3 Top Dividend Stocks to Buy and Hold for the Next 20 Years |
Dividend stocks are great long-term investments. They've outperformed non-dividend-paying stocks by more than 2-to-1 over the long term. The best returns have come from companies that pay a growing dividend.
Read more
2025-03-27 (fool.com)
2 Recession-Proof Dividend Stocks to Buy and Hold |
Fears of a looming recession seem to be rising, partly fueled by President Donald Trump's macroeconomic policies. While it's impossible to predict whether an economic downturn is indeed coming, it's not a bad idea for investors to purchase shares of companies that are likely to perform relatively well in case it does happen.
Read more
2025-03-25 (nasdaq.com)
Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension? |
Medtronic's Hypertension business is on the brink of a major expansion, driven by its Simplicity blood pressure procedure.
Read more
2025-03-25 (burzovnisvet.cz)
Why does Barclays see a shopping opportunity in Medtech shares? - .cz - shares, courses, stock exchange, forex, commodities, IPO, bonds - news
Barclays said in Monday that it sees attractive entry positions in Medtech shares, as the recent weakening of some sector leaders has created an opportunity to buy despite good group results since the beginning of the year. "BSX behaves as if returning, from the minimum of March 10th increased by 7.0 % and the performance of confectionery, which for […]
Read more
2025-02-25 (devdiscourse.com)
Health Industry Updates: Key Developments and Investments | Technology
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen investing $200 million in India. Medtronic received FDA approval for a Parkinson's device, while U.S. agencies delay a 'healthy' food label decision. Regeneron shows progress in gene therapy for congenital deafness.
Read more
2025-02-19 (trendlyne.com)
Market closes flat, KIMS signs a 7-year agreement with UAIMS Hospital to provide medical services
Stock market live updates for February 18, 2025. Follow this blog as we add live news and announcements on India's listed companies and the share market.
Read more
2025-02-18 (benzinga.com)
Medtronic, Fluor and 3 stocks to Watch Heading into Tuesday - Baidu (NASDAQ:BIDU), Fluor (Nyse:flr) -
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Read more
2025-02-08 (marketbeat.com)
Cantor Fitzgerald Investment Advisors L.P. Cuts Stake in Medtronic plc (NYSE:MDT)
Cantor Fitzgerald Investment Advisors L.P. reduced its holdings in shares of Medtronic plc (NYSE:MDT - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 204,498
Read more